ration, the signal for I is quenched when it associates with R and the signal is turned on when I is displaced by A. 4 To date, the vast majority of IDA studies utilize optical indicators that produce a change in absorbance or luminescence. 5, 6 In principle, IDAs based on other spectroscopic methods have specific performance advantages. For example, NMR spectroscopy has greater signal dispersion, which favors the creation of multiplex sensing assays. 7 In addition, the ability to manipulate NMR spin states using multipulse sequences allows selective signal detection and spectral editing. Furthermore, the ability of MRI to visualize signals that are spatially deep within physical objects, including living subjects, raises the intriguing idea of buried IDAs that are detected remotely. The largest technical drawback with an NMR-based IDA is the relatively low detection sensitivity. Ongoing improvements in NMR signal enhancement are expected to ameliorate this concern, 8 as well as the invention of generalizable methods that magnify the theoretical maximum signal from I. A potential solution to the latter problem is to devise IDAs with catalytic cycles that produce amplified signals. 9 Although inherently appealing, the catalysis design challenges are considerable, especially with low molecular weight analytes.
Here, we describe an alternative design concept that is well suited to NMR spectroscopy -a rapidly exchanging association system that allows R to quench the excited state of multiple I. Fig. 1A is a non-covalent version of this PRE switching concept but with a new performance feature. Not only is the assay signal intensity 'switchedon' by displacement of a 19 F-labeled I from a suitably designed R with appended relaxation agent, there is potential for signal amplification since substantially more I molecules are 'switched-on' than one molar equivalent of R (see Fig. S2c for ESI † schematic picture).
The prototype IDA used in this preliminary study exploits the phosphate anion recognition properties of synthetic zinc(II)-bis(dipicolylamine) (ZnBDPA) receptors. 19 Prior work has shown that ZnBDPA coordination complexes have high affinity for highly charged polyphosphates like pyrophosphate (PPi) in water (K a B 10 À7 M
À1
). 20 Two homologous receptors were prepared by covalently linking a ZnBDPA unit to a paramagnetic relaxation agent -a proxyl spin label in the case of receptor 1 11b and a Gd 3+ -DOTA in the case of 2 (Fig. 1B) . 21 The 19 F-labeled phosphate indicator, 3, was designed to associate rapidly and relatively weakly with the ZnBDPA unit in 1 or 2 (K a B 10 À4 M
). 20 As expected, 19 F NMR titration experiments showed that the peak for 3 broadened substantially upon addition of sub-stoichiometric amounts of receptor 1 or 2 with a concomitant reduction in peak height (Fig. 2 and Fig. S1 , ESI †). Specifically, addition of either 1 or 2 (0.25 mM) reduced the relative peak height for 3 (1 mM) by 82%. A subsequent titration of the 1 : 3 admixture with PPi showed that only 0.25 mM of PPi was needed to fully restore the peak height to a value corresponding to 1 mM of 3 ( Fig. 2 and Fig. S2 , ESI †). Essentially the same amount of signal restoration was observed when PPi was added to the homologous IDA admixture of 2 : 3 (compare Fig. S3 and S4 , ESI †).
Further characterization of the PRE was gained by measuring 19 F NMR relaxation times for indicator 3 in the presence and absence of the other assay additives. As listed in Table 1 , T 2 for the 19 F signal of free 3 (1 mM) was 1.13 AE 0.15 s, and it decreased to 0.03 AE 0.01 s after addition of proxyl-appended receptor 1 (0.25 mM). A subsequent addition of excess PPi restored T 2 to its original value (1.08 AE 0.09 s). These results confirm the rapidly exchanging association of 1 and 3 leading to a substantial PRE on 3. The PRE is lost when the added PPi associates strongly with 1 and prevents 1 from making long-lived intermolecular contact with 3. A similar decrease in T 2 relaxation was observed when 3 (1 mM) was mixed with Gd 3+ -DOTA-appended receptor 2 (0.25 mM). But the subsequent addition of excess PPi only returned the T 2 value for 3 to 50% of its original value (Table 1) . We attribute this incomplete recovery of T 2 to the known propensity of small oxyanions like 3 to directly coordinate with the metal center in the Gd 3+ -DOTA unit of 2.
22 This provides a second, non-competitive relaxation pathway for indicator 3 that is not blocked by association of PPi to the ZnBDPA unit in 2.
Evidence supporting this rationalization is the observation that the addition of apo-2 (a version of 2 without zinc cations) also decreases the T 2 for 3 in the presence or absence of added PPi (Table 1 and Fig. S5 , ESI †). So while receptors 1 and 2 are equally effective in a spectroscopic IDA like Fig. 2 , they are not expected to exhibit the same performance if the IDA is detected as a T 2 -weighted image using MRI. In this latter case, a smaller image voxel dynamic range is expected with 2 due to the incomplete restoration of T 2 upon titration with PPi. Most of the above experiments used standard conditions of 0.25 mM of R and 1.0 mM of I. These relatively high concentrations enabled the spectra to be rapidly acquired in 8 scans. While detection sensitivity could be enhanced by simply increasing the F NMR IDA that can detect cell death. To demonstrate the basic concept we treated an admixture of 1 : 3 with two separate vesicle dispersions, zwitterionic vesicles composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC, mimic of healthy cells) and anionic vesicles containing 20 mol% of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylserine (POPC : POPS 80 : 20, mimic of dead/dying cells). As shown in Fig. 3 , the 19 F NMR IDA can readily differentiate the two vesicle compositions. With further development this 19 F NMR IDA could become broadly useful in new types of biomedical assays that monitor changes in membrane surface charge or the number of anionic cells. An example of the former is a phospholipase D assay that monitors enzyme catalyzed conversion of zwitterionic phosphatidylcholine to anionic phosphatidic acid, a biochemical process that is implicated in cancer. 23 An example of the latter is an antibiotic drug discovery assay that monitors changes in the number of anionic bacterial cells. 24 This work was supported by the NIH and the University of Notre Dame. We are grateful to Dr J. Zajicek for assistance with the NMR experiments.
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